Literature DB >> 3089465

Angina pectoris-like pain provoked by intravenous adenosine in healthy volunteers.

C Sylvén, B Beermann, B Jonzon, R Brandt.   

Abstract

In a study to characterise the chest pain induced by adenosine this agent was given as a bolus into a peripheral vein to six healthy volunteers (five men) aged 30-44. On the first day the maximum tolerable dose was determined in each case. On the second day three doses of adenosine (one third, two thirds, and the full maximum tolerable dose) and three doses of saline were given single blind in randomised order. Thereafter aminophylline 5 mg/kg was given and the procedure repeated in a different randomised order. On the third day between two thirds and the full maximum tolerable dose was given followed by 10 mg dipyridamole intravenously and a second injection of the same dose of adenosine. Heart rate and atrioventricular blocks were recorded by electrocardiography. One minute after each dose of adenosine the chest pain was scored. The maximum tolerable dose of adenosine ranged from 10.6 to 37.1 mg. All subjects experienced uneasy central chest pain provoking anxiety. The pain radiated to the shoulders, ulnar aspect of the arms, epigastric area, back, and into the throat. The pain began about 20 seconds after the injection and lasted 10-15 seconds. Increasing the dose of adenosine increased the intensity of the pain. Administration of aminophylline reduced the pain significantly. Second degree heart block was recorded in five of the six subjects during the time that the pain was experienced. After aminophylline no block was observed. Dipyridamole increased the intensity of pain. The duration of second degree heart block increased in four of the subjects, and in two of these third degree heart block occurred. These findings suggest that adenosine released from the myocardium during ischaemia induces angina pectoris by stimulating theophylline sensitive receptors.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3089465      PMCID: PMC1341169          DOI: 10.1136/bmj.293.6541.227

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  11 in total

1.  The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart.

Authors:  A N Drury; A Szent-Györgyi
Journal:  J Physiol       Date:  1929-11-25       Impact factor: 5.182

2.  Role of purines in acetylcholine-induced coronary vasodilation.

Authors:  J Schrader; C I Thompson; G Hiendlmayer; E Gerlach
Journal:  J Mol Cell Cardiol       Date:  1982-07       Impact factor: 5.000

3.  Flow and pressure responses of coronary arteries and veins to vasodilating agents.

Authors:  J C Sylven; J A Armour; G A Klassen
Journal:  Can J Physiol Pharmacol       Date:  1984-11       Impact factor: 2.273

4.  Effect of adenosine on carotid chemoreceptor activity in the cat.

Authors:  D S McQueen; J A Ribeiro
Journal:  Br J Pharmacol       Date:  1981-09       Impact factor: 8.739

5.  The release of adenosine and inosine from canine subcutaneous adipose tissue by nerve stimulation and noradrenaline.

Authors:  B B Fredholm; A Sollevi
Journal:  J Physiol       Date:  1981       Impact factor: 5.182

6.  Dipyridamole inhibition of adenosine metabolism in human blood.

Authors:  R E Klabunde
Journal:  Eur J Pharmacol       Date:  1983-09-16       Impact factor: 4.432

7.  [Effect of myocardial ischemia on adenine nucleotide metabolism].

Authors:  A I Kuz'min; T V Saprygina; V D Vakhliaev; V G Kukes; A L Syrkin
Journal:  Kardiologiia       Date:  1984-06       Impact factor: 0.395

8.  On the specificity and type of receptor involved in carotid body chemoreceptor activation by adenosine in the cat.

Authors:  D S McQueen; J A Ribeiro
Journal:  Br J Pharmacol       Date:  1983-10       Impact factor: 8.739

9.  Coronary flow regulation in patients with ischemic heart disease: release of purines and prostacyclin and the effect of inhibitors of prostaglandin formation.

Authors:  A Edlund; B Berglund; D van Dorne; L Kaijser; J Nowak; C Patrono; A Sollevi; A Wennmalm
Journal:  Circulation       Date:  1985-06       Impact factor: 29.690

10.  Adenosine stimulates respiration in man.

Authors:  A H Watt; P A Routledge
Journal:  Br J Clin Pharmacol       Date:  1985-11       Impact factor: 4.335

View more
  24 in total

1.  Effect of oral aminophylline in patients with angina and normal coronary arteriograms (cardiac syndrome X).

Authors:  P M Elliott; K Krzyzowska-Dickinson; R Calvino; C Hann; J C Kaski
Journal:  Heart       Date:  1997-06       Impact factor: 5.994

2.  Adenosine in heart and lung disease. Proceedings of the first Cardiothoracic Institute Workshop. 30 March 1988, London. Abstracts.

Authors: 
Journal:  Postgrad Med J       Date:  1988-10       Impact factor: 2.401

3.  On the pathogenesis of angina pectoris and its silence.

Authors:  T N James; L Rossi; G R Hageman
Journal:  Trans Am Clin Climatol Assoc       Date:  1989

Review 4.  Pharmacological rationale for the clinical use of caffeine.

Authors:  J Sawynok
Journal:  Drugs       Date:  1995-01       Impact factor: 9.546

5.  Lower threshold for adenosine-induced chest pain in patients with angina and normal coronary angiograms.

Authors:  B Lagerqvist; C Sylvén; A Waldenström
Journal:  Br Heart J       Date:  1992-09

Review 6.  Pharmacologic radionuclide myocardial perfusion imaging.

Authors:  Sachin M Navare; Athanasios Kapetanopoulos; Gary V Heller
Journal:  Curr Cardiol Rep       Date:  2003-01       Impact factor: 2.931

7.  An open-label trial of theophylline for functional chest pain.

Authors:  Satish S C Rao; Ranjit S Mudipalli; Victor Mujica; Craig L Utech; Xing Zhao; Jeffrey L Conklin
Journal:  Dig Dis Sci       Date:  2002-12       Impact factor: 3.199

Review 8.  Caffeine and anaerobic performance: ergogenic value and mechanisms of action.

Authors:  J K Davis; J Matt Green
Journal:  Sports Med       Date:  2009       Impact factor: 11.136

9.  Adenosine-induced respiratory stimulation in man depends on site of infusion. Evidence for an action on the carotid body?

Authors:  A H Watt; P G Reid; M R Stephens; P A Routledge
Journal:  Br J Clin Pharmacol       Date:  1987-04       Impact factor: 4.335

10.  [Pathophysiology of ischemic cardiac pain.].

Authors:  T Münzel; E Bassenge
Journal:  Schmerz       Date:  1988-09       Impact factor: 1.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.